v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (9,093,931) $ (6,918,320)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 365,659 643,312
Amortization of finance leases 12,811 11,233
Amortization on discount associated with finance leases 0 24,321
Amortization of debt discount and other debt-related items 214,298 522,107
Accretion of reclamation liability 109,915 100,162
Interest expense paid with common stock 142,422 116,603
Research and development expense paid with common stock 1,487,476 0
Gain on extinguishment of liability (845,000) 0
Loss on conversion of debt 1,196,880 193,523
Employee and director share based compensation 0 56,184
Change in fair value of derivative instruments 1,190,803 756,118
Share of net (income) loss of equity-method investments (41,438) 575,904
Other 175,943 9,557
Changes in operating assets and liabilities:    
Accounts receivable (378,808) (384,277)
Prepaid expenses (48,672) (38,568)
Deposits - asset (60,000) 0
Other assets (6,270) (142,895)
Accounts payable 339,379 (96,069)
Accrued expenses, other liabilities, and deposits (606,943) 502,737
Deferred revenue 757,958 0
Other liabilities 125,000 237,772
Net cash used in operating activities (4,962,518) (3,830,596)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of mineral rights and properties, plant and equipment (240,873) (355,939)
Acquisition of intangible asset (180,000) 0
Investment in Hexas SAFE Note (366,667) 0
Payments on contractual commitments associated with derivatives (120,000) (1,500,000)
Payment of reclamation bond deposit (150,000) 0
Other (28,790) (34,000)
Net cash used in investing activities (1,816,330) (2,619,939)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Principal payments on financing leases (23,650) (41,656)
Principal payments of debt (100,000) (150,000)
Issuances of debt 10,000,000 2,000,000
Proceeds from the issuance of common stock 0 1,463,710
Common stock issuance costs (145,000) (140,120)
Net cash provided by financing activities 9,731,350 3,131,934
Net increase (decrease) in cash and cash equivalents 2,952,502 (3,318,601)
Cash and cash equivalents at beginning of period 954,271 3,785,577
Cash and cash equivalents at end of period 3,906,773 466,976
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Recognition of operating lease liability and right of use asset 3,548,557 0
Issuance of common stock for LINICO acquisition-related payable 1,860,000 0
Acquisition of plant and equipment from Marathon SAFE Note 12,000,000 0
Issuance of common shares with debt 0 250,000
Investment acquired with payable 0 1,285,961
Issuance of common shares for due diligence and commitment fees 0 85,000
AST Lease Amendment [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common stock for lease amendment 2,482,200 0
Debt and Accrued Interest Converted Into Common Shares [Member]    
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Fair value of stock issued (1,490,624 shares) 4,001,243 894,773
Sierra Springs Opportunity Fund, Inc. (SSOF) [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in SSOF (300,000) (480,000)
RenFuel Note Receivable [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Funding of RenFuel note receivable $ (430,000) $ (250,000)